Author: pharmia

  • When Administration Stifles Clinical Care: The Real Cost of Bureaucratic Burden in Pharmacy

    When Administration Stifles Clinical Care: The Real Cost of Bureaucratic Burden in Pharmacy

    Quebec pharmacists lose hundreds of hours every year to administrative tasks. Meanwhile, patients wait — and the healthcare system runs out of breath.

    A clinical activity in full expansion

    In 2023, Quebec’s community pharmacies delivered more than 7 million clinical acts — a 16% increase in a single year. Since 2019, that’s a 51% growth in clinical activity. Quebec pharmacists have become, de facto, the first point of contact in the healthcare network: accessible without an appointment, seven days a week, in more than 1,900 pharmacies across the province.

    But this clinical growth has happened without the resources to support it.

    The shortage that amplifies everything

    Quebec is short roughly 1,150 pharmacists. The vacancy rate in community pharmacy reaches 12%, four times the provincial average across all sectors. In 2024, one million replacement hours were needed just to maintain basic service.

    And a significant share of those hours never even reaches the patient.

    The daily reality behind the counter

    The typical day of a community pharmacist in 2026 isn’t only clinical work. It’s also:

    • Answering calls from other pharmacies and physicians to clarify prescriptions, confirm therapies, or coordinate file transfers.
    • Documenting every clinical intervention in often outdated systems, then faxing — yes, faxing, in 2026 — follow-ups to prescribers.
    • Verifying, before each act, whether it complies with the regulatory framework in force: laws, regulations, agreements, exceptions.
    • Filling out administrative forms that have no clinical value but are required by the system.
    • Calling patients back for follow-ups the system doesn’t handle automatically.

    These tasks are necessary in principle, but their execution remains largely manual, fragmented, and time-consuming.

    The numbers tell the story

    In Quebec

    According to the 2024 survey of its members by the APPSQ (Quebec’s professional association of salaried pharmacists), most salaried pharmacists report a workload that is still far too heavy and conditions that are poorly suited to clinical practice. Even more revealing: 65% of respondents fear that the new acts introduced by Bill 67 will worsen this overload if no concrete administrative relief accompanies the expanded scope of practice.

    The AQPP (Quebec association of pharmacy owners) sounded the alarm as early as March 2024, publicly calling for the removal of certain administrative rules surrounding clinical activities. The message was clear: rules designed to frame practice end up restricting patients’ access to care. AQPP president Benoit Morin summed it up this way: the barriers must come down so that the 7,000 pharmacists in the network can serve their patients effectively.

    Across Canada

    The Quebec picture fits within a documented national trend. The Canadian Medical Association (CMA) estimates that Canadian healthcare professionals collectively lose 18.5 million hours per year on unnecessary administrative tasks — the equivalent of 55.6 million patient visits. And according to the CMA, 85% of that work comes from the healthcare system’s own processes, not from the clinical complexity of the cases.

    For pharmacists specifically, data from the Canadian Pharmacists Association (CPhA) reveals a direct link between administrative burden and burnout: pharmacists experiencing burnout spend an average of 7.5 hours per week on administrative tasks, compared to 4.3 hours for those who aren’t. In 2023, 79% of pharmacy professionals in Canada were at risk of burnout.

    Internationally

    The phenomenon isn’t unique to Canada. In the United States, recent studies report that pharmacists can spend up to 90% of their time on administrative tasks rather than direct patient care. Pharmacy staff burnout has reached historic levels there, largely attributed to workload and chronic understaffing.

    Bill 67: a major step forward, but incomplete

    Adopted by the National Assembly, Bill 67 represents a historic reform of Quebec’s pharmacy legal framework. It promises to substantially expand pharmacists’ professional autonomy:

    • Prescribing medication with fewer restrictions
    • Extending prescriptions without arbitrary deadlines
    • Substituting medications in more clinical situations
    • Replacing certain administrative rules with the pharmacist’s professional judgment

    The Ordre des pharmaciens du Québec (OPQ) hailed the reform as “a historic step for access to care.” The draft regulation was published in the Gazette officielle in June 2025 for public consultation, with updates in October 2025.

    But adopting the law doesn’t solve everything. The APPSQ underlined this in its November 2025 statement: current working conditions in community pharmacy still cannot absorb the new responsibilities introduced by Bill 67. Without concrete relief from the administrative burden, expanding the scope of practice amounts to adding more weight onto already overloaded shoulders.

    La Presse reported in December 2025 that the expansion of pharmacists’ powers was slow to materialize in practice, despite the law’s adoption.

    The real problem: systems built for another era

    The administrative burden in pharmacy is no accident. It’s the result of systems designed decades ago, when the pharmacist’s role was essentially limited to dispensing medication. These systems — pharmacy software, prescriber communication processes, billing mechanisms, documentation protocols — haven’t evolved at the same pace as the practice.

    The result is a structural mismatch:

    • Fragmented inter-professional communication: fax remains the dominant communication mode between pharmacies and prescribers in most practice settings.
    • Redundant documentation: a single clinical act can require documentation in the pharmacy software, a paper form, a fax to the prescriber, and a chart note.
    • Manual regulatory verification: before each expanded act, the pharmacist must mentally (or physically) review the applicable regulatory framework — laws, regulations, AQPP-MSSS agreements, collective prescriptions — to confirm the act is permitted.
    • Complex billing: the billing system for clinical acts, governed by the AQPP-MSSS agreement, includes dozens of codes, conditions, and exceptions that vary by act type, patient status, and clinical situation.

    What technology can change — and what it can’t

    Technological solutions exist, and some are already deployed in other jurisdictions or other healthcare sectors. Among the most promising avenues:

    Automated clinical documentation

    Artificial intelligence can now capture, structure, and write clinical documentation from a conversation between the professional and the patient. Platforms like Abridge (which reached $100M in annual revenue automatically documenting medical consultations) show that the technology is mature. The same principles apply in pharmacy: capture the clinical exchange, generate the note, the follow-up, and the prescriber communications — automatically.

    Intelligent regulatory verification

    Instead of forcing the pharmacist to manually consult the legal framework before each act, a smart tool can cross-reference the clinical situation with the current regulations and confirm compliance instantly. That’s the “compliance by design” approach: the system checks for you, in real time.

    Information system integration

    Communication between pharmacies, prescribers, and healthcare facilities should be digital, bidirectional, and instant. The Dossier Santé Québec (DSQ) is a step in that direction, but its integration into daily workflows remains incomplete.

    Billing automation

    Billing for clinical acts can be automatically derived from the documented act, eliminating double entry and coding errors.

    What technology doesn’t replace

    The pharmacist’s clinical judgment. The trust relationship with the patient. The assessment of a complex situation that requires experience and context. Technology isn’t there to replace the pharmacist — it’s there to give back the time to do what they were trained for.

    The real issue: time

    Every hour spent filling out a form, faxing a document, or manually checking a regulatory framework is one less hour at the counter with a patient. In a labour shortage context, every hour counts.

    The question isn’t whether pharmacists can do more. They are already doing more, every year, with fewer people. The question is how much longer we keep wasting time on processes that could be automated — and how many patients miss out on care that could have been provided if the pharmacist had had five more minutes.

    Bill 67 gives pharmacists new powers. It’s time to give them the tools to exercise them.


    Pharmia builds artificial intelligence tools designed specifically for Quebec pharmacists — automated clinical documentation, real-time regulatory verification, and instant access to the entire normative framework of pharmacy practice in Quebec.


    References

    1. AQPP — “Pharmacy owners call for the removal of certain administrative rules” (March 2024)
      monpharmacien.ca
    2. La Presse — “Pharmacy owners call for the removal of certain administrative rules” (March 2024)
      lapresse.ca
    3. APPSQ — 2024 survey on irritants in community pharmacy
      appsq.org
    4. APPSQ — Statement on Bill 67 (November 2025)
      appsq.org
    5. Canadian Medical Association (CMA) — Administrative burden: facts and figures
      cma.ca
    6. Canadian Pharmacists Association (CPhA) — National survey on the mental health of pharmacy professionals (2023)
      pharmacists.ca
    7. Ordre des pharmaciens du Québec (OPQ) — “Bill 67 adopted: a historic step for access to care”
      opq.org
    8. OPQ — “Bill 67 adopted: fewer administrative barriers, more autonomy”
      opq.org
    9. La Presse — “Expansion of pharmacists’ powers slow to be implemented” (December 2025)
      lapresse.ca
    10. OPQ — Bill 67 draft regulation, Gazette officielle (June 2025)
      opq.org
    11. Profession Santé — “Pharmacy irritants: APPSQ unveils its survey” (August 2024)
      professionsante.ca
    12. Portail de l’assurance — “Pharmacists play a growing role in primary care” (April 2026)
      portail-assurance.ca
    13. Sully.ai — “Top 3 AI Pharmacists in 2026”
      sully.ai
    14. MedMe Health — “An Overview of AI in Pharmacy” (2025)
      medmehealth.com
    15. Contrary Research — “Abridge Business Breakdown”
      research.contrary.com
  • When technology forgets those who need it most

    When technology forgets those who need it most

    The paradox of digital health

    We live in a world where you can order medications online, consult a pharmacist by video, and receive medication reminders on your phone. Healthcare has gone digital. It’s an extraordinary leap forward.

    Except for those who need it most.

    In Quebec, people aged 65 and over make up nearly 21% of the population — and that number keeps climbing every year. They’re the ones taking the most medications, having the most interactions with their pharmacist, and standing to gain the most from well-designed digital tools.

    And yet, they’re the ones being left behind.

    Screens that don’t forgive

    The reality is that most health applications are designed by teams of 25-to-35-year-olds, for users aged 25 to 35. Buttons are small. Text is thin. Flows are complex. Error messages assume you know what an “expired token” means.

    For a 72-year-old taking eight medications a day, with reduced vision and no computer training, every screen can become a wall.

    And when technology becomes an obstacle, people abandon it. Not because they’re incapable — because nobody thought of them.

    At Pharmia, we decided to think of them

    When our designer started working on Pharmia’s interface, one question came up very quickly: who are we really building for?

    Not early adopters. Not 30-year-old pharmacists who navigate with their eyes closed. For everyone — including the 78-year-old patient who needs to understand her lab results, and the 62-year-old pharmacist who wants a tool that helps, not one he has to learn.

    What we actually changed

    Readability first. Every text element was reviewed to be effortlessly readable. Generous font sizes, high contrast, clear visual hierarchy. If someone has to squint, we’ve failed.

    Simplified flows. Fewer clicks, fewer choices per screen, less technical jargon. Essential information is always front and center. Secondary features exist, but they don’t clutter the main experience.

    Clear, reassuring feedback. When a user takes an action, they immediately know what happened. No doubt, no ambiguity. A clear message, in human language.

    Intuitive navigation. We eliminated hidden menus, unlabeled icons, and shortcuts you have to guess. Every button says what it does. Every page says where you are.

    Design tested with real users. Not just personas in a Figma file — pharmacists in the field, real patients, concrete feedback that shaped every iteration.

    The truth we own: it’s never finished

    We could stop here and congratulate ourselves. But the reality is that accessibility isn’t a destination — it’s an ongoing process.

    Every update, every new feature is an opportunity to regress if you’re not paying attention. And needs evolve: what works for a 65-year-old today might not work for them in five years when their eyesight has changed again.

    There’s always room to improve. That’s a core belief at Pharmia, not just a tagline. We listen, we test, we adjust. Continuously.

    What’s coming: AI in service of accessibility

    Adapting a visual interface is essential. But for some people, the screen itself is the problem. No matter how large the text or how simple the flow — handling a phone or computer remains a challenge.

    That’s why Pharmia is currently developing AI-assisted voice consultations.

    The idea is simple: a patient will be able to interact with their pharmacist or get information about their medications through voice, without navigating an interface. Ask a question, get a clear answer, all in a natural conversation.

    This isn’t science fiction — it’s an active project here. Because if we truly believe technology should serve everyone, we need to go beyond the screen.

    Final thoughts

    The population is aging. Healthcare needs are growing. Technology is advancing at full speed. If we don’t make the conscious effort to include everyone in this progress, we create a two-tier healthcare system — those who master digital tools, and those we leave behind.

    At Pharmia, we refuse that divide. Our designer understood this from day one, and that vision guides every interface decision. Not because it’s trendy. Because it’s necessary.

    And we’ll keep going. Because there’s always a way to do better.

  • Your Pharmacy Could Soon Close Its Doors. Here Is Why.

    Your Pharmacy Could Soon Close Its Doors. Here Is Why.

    A message from your pharmacists to the people of Quebec because your access to healthcare concerns all of us.


    What the government is doing, and why it directly concerns you

    Right now, in Quebec City, an amendment to Bill 15 is about to change the life of every Quebecer who sets foot in a pharmacy, that is, practically everyone.

    The government is about to cap the fees that pharmacists can charge private insurers. In other words: they want to force pharmacies to operate on revenues that do not even cover their actual costs.

    This is not an abstract debate between politicians and lobbyists. It is your neighbourhood pharmacy that is threatened. It is your access to healthcare that is at stake.

    What will change in your daily life, concretely

    Your pharmacy will close earlier

    Are you used to stopping by the pharmacy on Saturday afternoon, or in the evening after work? If this amendment passes, many pharmacies will no longer be able to afford staying open outside peak hours. Evenings, weekends, holidays, the time slots when you need them the most will be the first to go.

    You will wait longer at the emergency room

    In recent years, with Bills 31 and 41, your pharmacist can prescribe an antibiotic for a urinary tract infection, treat your conjunctivitis, vaccinate you, and adjust your medications. Quick, accessible care, no appointment needed. If pharmacies can no longer afford to offer these services, those patients go back to the ER. The ER that is already overflowing. The ER where you wait 12, 14, 18 hours.

    Your neighbourhood pharmacist will disappear

    There are 1,900 community pharmacies in Quebec. Some are the only source of healthcare in their village. If we cut the revenues of these pharmacies, it is the regions that suffer first. Not Montreal. Not Quebec City. The small villages where your grandmother picks up her heart medication, where the pharmacist is the only healthcare professional within a 45-minute drive.

    Your employer will cut your insurance coverage

    If the government caps what pharmacists can charge private insurers, the insurers will adjust their grids, but not necessarily in your favour. The domino effect is predictable: group insurance plans will be renegotiated, deductibles increased, coverage reduced. You will pay more out of pocket for the same medications.

    Your pharmacist will have less time to talk to you

    The salaried pharmacist who takes five minutes to explain the side effects of your new medication. The pharmacist who calls your doctor to flag a dangerous interaction. The family pharmacist who has known your file by heart for ten years. All of that takes time and resources.

    The real winners: insurers and multinationals, not you

    They want you to believe this measure is in your interest. Yet it is not your pharmacist’s fees that are driving up your insurance premiums. It is the rising costs of specialty medications, treatments that cost tens of thousands of dollars a year and are manufactured by multinational pharmaceutical companies.

    Your premiums are going up? It is because of these overpriced medications, not because of the pharmacist who serves you at the counter. The AQPP says it clearly: the real debate should be about the rising cost of medications, not about the revenues of neighbourhood pharmacies.

    By going after pharmacies rather than the true sources of pressure on the system, the government is protecting the interests of private insurers and pharmaceutical giants, and you are the one paying the price.

    The paradox that should outrage everyone

    The government expanded the role of pharmacists with Bill 67, a law that told them: “You are capable of doing more. Prescribe, draw blood, vaccinate, treat.” Pharmacists accepted. They trained. They invested.

    And now, the same government is about to cut their revenues. Concretely, it is telling them: “Figure it out.”

    It is like asking a contractor to renovate an entire building, then telling them you will only pay half the bill, after the work has already started.

    The financial impact the government does not want you to see

    The amendment represents an approximately 25% decrease in revenues for community pharmacies.

    A quarter of revenues. Gone. Overnight.

    • 25% less revenue means 25% less investment: fewer staff, less training, fewer technologies, fewer clinical services for you.
    • This revenue gap does not come from “greedy” pharmacists. It comes from the fact that public plan rates have not been properly indexed for over 20 years. Meanwhile, everything has gone up: rent, salaries, insurance, software, training.
    • Instead of correcting the chronic underfunding of the public plan, the government is choosing to level down.
    • For a typical pharmacy, this revenue loss is equivalent to having to cut positions, reduce opening hours, and abandon the very services that Bill 67 asks them to provide.

    Who is behind this measure?

    The amendment was proposed by Québec solidaire MNA Alexandre Leduc, adopted without consulting pharmacists, without notice, and in the middle of negotiations between the AQPP and the government.

    The AQPP withdrew from the negotiating table, an unprecedented move. Its president, Benoit Morin, called the amendment a “massive slap in the face.”

    The cases of “overbilling” that fuelled the media debate involve a handful of players in specialty medications. The AQPP had proposed targeted solutions to address these abuses. The government ignored them and chose to punish all 1,900 pharmacies in Quebec.

    The industry is unanimous: this is unacceptable

    The entire profession, owners, employees, independents, technicians is on the same side. The professional orders, the associations, the banners: no one supports this amendment. Because everyone knows that if pharmacies fall, it is the patients who pay the price.

    It is an entire profession sounding the alarm to protect your access to healthcare.

    What the government should do instead

    The solution is simple: instead of cutting pharmacy revenues, the government must increase RAMQ rates to reflect the real cost of pharmaceutical services in 2026, and tackle the true causes of rising premiums the costs of specialty medications and the practices of major insurers.

    You do not fix an underfunded system by impoverishing those who hold it together.

    What you can do

    Share this article. Show it to your family, your colleagues, your neighbours. The more people understand what is happening, the more pressure the government will face to back down.

    Write to your MNA. It is simple and takes two minutes. Go to jappuiemonpharmacien.com to send a letter directly to your elected representative.

    Ask them:

    • “Do you find it acceptable that I would have to wait 18 hours in the ER for a urinary tract infection that my pharmacist could have treated in 20 minutes?”
    • “Is it acceptable that I lose the care provided by my family pharmacist for my chronic pain that has lasted for years?”
    • “Who will adjust my mother’s diabetes medications if her neighbourhood pharmacy closes?”
    • “My pharmacy is open until 9 PM, it is the only place I can go after work, do you find it acceptable that it closes at 5 PM?”

    Because that is exactly what is coming if no one reacts.


    References

  • Pharmia Atlas vs Open Evidence: When AI Finally Speaks the Quebec Pharmacist’s Language

    Pharmia Atlas vs Open Evidence: When AI Finally Speaks the Quebec Pharmacist’s Language

    Testimony from a pharmacy owner


    I’ve been a pharmacy owner for several years. I’ve tested my share of tools. I’ve heard my share of tech promises. So when my team told me about Pharmia Atlas, I did what I always do: I tested it myself. And to compare, I asked the same question to Open Evidence, a well-known medical AI tool in academic circles.

    The question was simple, concrete, the kind of situation we deal with every week at the counter: Which vaccines are free and recommended for a 71-year-old diabetic patient? What would be the recommended administration schedule?

    A routine case. A real patient. An answer I need in thirty seconds, not thirty minutes.

    Open Evidence: A Scholarly Answer, But Not for Here

    Open Evidence gave me a structured answer. The recommended vaccines were: influenza, pneumococcal, shingles, COVID-19, tetanus-diphtheria-pertussis, and even hepatitis B. The sources? American guidelines — AACE, ADA, CDC. Solid on paper.

    But when I read that the recommended pneumococcal vaccine is “PCV15 or PCV20 followed by PPSV23,” I check out. That’s not the nomenclature we use in Quebec. And most importantly, when I look for the answer to my real question — is it free for my patient? — Open Evidence tells me: “The availability of free vaccination varies depending on the healthcare system and the patient’s insurance program.”

    In other words: figure it out yourself.

    The tool even suggests I explore the “specific free vaccination programs available in my region.” That’s exactly what I was trying to do by asking the question.

    Pharmia Atlas: The Answer I Would Have Written Myself

    Pharmia Atlas’s answer stopped me in my tracks. Not because it was longer or more impressive. Because it was right.

    Right off the bat, Atlas tells me it’s consulting the PIQ — Quebec’s Immunization Protocol. Already, I know I’m in the right framework. Then, a clear table with five vaccines: influenza, conjugate pneumococcal, shingles, COVID-19, and Tdap. For each one, the specific eligibility for free coverage under Quebec’s public program, and the precise administration schedule with recommended and minimum intervals.

    A few details that convinced me the tool truly understands my context:

    • It recommends Pneu-C-21 (Capvaxive) as a single dose, and specifies that Pneumovax 23 is no longer used in the public program. This is a recent change that even some colleagues don’t know about yet.
    • For influenza, it specifies to prefer Fluad or Fluzone High Dose for those 75 and older with chronic disease. This isn’t generic information — it’s what the PIQ recommends.
    • For shingles, it notes that at 71, free coverage applies based on age, regardless of diabetes. A detail that changes the conversation with the patient.
    • The COVID-19 products available for free are named: Comirnaty and Spikevax. Not “according to current health authority recommendations.”

    Where Open Evidence cites the American Association of Clinical Endocrinology and Diabetes Care, Atlas directly cites PIQ sections — the document I use every day in my practice.

    What It Changes at the Counter

    The difference isn’t measured in the number of recommended vaccines. It’s measured in validation time.

    With Open Evidence, I would have had to open the PIQ alongside it, verify each recommendation, adapt the American nomenclature to our reality, and confirm the free coverage myself. Twenty extra minutes of work. Multiplied by the dozens of vaccine consultations we do each week, that adds up to hours.

    With Pharmia Atlas, the answer was ready to use. I still verified — that’s my pharmacist reflex — and everything matched the PIQ. The sources were there, clickable, each one pointing to the relevant section.

    A Tool Made for Us

    This isn’t about good or bad tools. Open Evidence has its place in clinical research, in academic settings, when exploring international literature. But at the counter of a pharmacy in Quebec, facing a patient waiting for their answer, I need a tool that knows my healthcare system, my public coverage programs, my nomenclature.

    Pharmia Atlas didn’t impress me with prestigious references. It impressed me by giving me exactly what I would have looked up myself — but in thirty seconds instead of twenty minutes.

    That’s the real value of a clinical tool. Not replacing the pharmacist. Arming them.


    Pharmia Atlas is available for free for Quebec pharmacists. Try it at app.pharmia.ca/atlas.

  • Pharmia Atlas: The ChatGPT of Pharmacy

    Pharmia Atlas: The ChatGPT of Pharmacy

    Clinical Information at Your Fingertips

    In a pharmacist’s daily routine, clinical questions come up constantly. A drug interaction to verify between two molecules, a diabetic patient traveling abroad who needs vaccine advice, a pediatric dosage to validate quickly. Every day, pharmacists navigate between monographs, INESSS guidelines, PIQ protocols, Health Canada databases, and PubMed — a constant intellectual juggling act that eats into precious time.

    What if a tool could do that research for you, in seconds, using the reliable sources you already trust?

    That’s exactly what Pharmia Atlas promises.

    What Is Pharmia Atlas?

    Pharmia Atlas is an AI-powered clinical research assistant designed specifically for pharmacists in Quebec. Think of it as a ChatGPT, but trained for Quebec’s pharmaceutical reality: it understands your terminology, knows your reference sources, and responds in French.

    Unlike a traditional search engine that returns a list of links to sift through, Atlas analyzes your question, simultaneously queries multiple recognized clinical databases, and synthesizes a structured answer — with complete references for every claim.

    You ask a question in natural language. Atlas gives you a documented clinical answer.

    Reliable Sources, Not Hallucinations

    This is where Pharmia Atlas fundamentally stands apart from a generalist tool like ChatGPT. Every answer is grounded in verifiable clinical data. Atlas doesn’t “guess” a dosage or invent an interaction. It directly queries:

    • Health Canada — official monographs and safety alerts
    • PubMed — peer-reviewed scientific literature
    • FDA Drug Labels — American labels and warnings
    • INSPQ and several others

    Every source consulted is cited in the response. The pharmacist can verify, dig deeper, and validate independently. No black box: clinical transparency.

    Built for the Quebec Context

    Pharmia Atlas isn’t a translation of an American tool. It was designed from the ground up for Quebec’s practice environment.

    Responses are in French by default. The tool understands the mixed terminology (French-English) that pharmacists use daily. Priority references are the ones you know: INESSS, OPQ, INSPQ, the Pharmacy Act.

    When a pharmacist asks “What are the recommendations for antimalarial prophylaxis for a trip to Thailand?”, Atlas doesn’t settle for a generic answer. It consults CDC and INSPQ data, cross-references with the PIQ for recommended vaccinations, and presents everything in an actionable format — with doses, contraindications, and precise references.

    A Personal Workspace

    Beyond simple chat, Atlas offers a document workspace. Pharmacists can upload their own documents — internal protocols, practice guides in PDF, reference tables — and Atlas integrates them into its searches.

    A document shared in one conversation remains accessible in all future conversations. Have a therapeutic coverage protocol specific to your pharmacy? Upload it once and Atlas can reference it whenever the question comes up.

    The tool also supports contextual mentions: by tagging a patient or consultation, the pharmacist gives Atlas the context needed to provide personalized, relevant answers for the case at hand.

    Faster, More Complete, More Confident

    The time savings are tangible. Where a manual search means opening multiple tabs, cross-referencing information across different sources, and synthesizing results yourself, Atlas does this work in seconds.

    But it’s not just about speed. It’s also about completeness. When you search manually, you might consult two or three sources before stopping. Atlas queries about ten simultaneously and presents a synthesis you might not have reached on your own.

    As one pharmacist user testifies: “Pharmia Atlas is a real asset! I no longer need to spend several minutes on my research. I can ask all my questions and it answers with reliable references.”

    Safety at the Core of the Design

    Pharmia Atlas is a research aid tool, not a prescribing tool. Every response comes with a reminder: information must be verified by the pharmacist. AI doesn’t replace clinical judgment — it empowers it.

    User data is securely hosted. Conversations and documents remain private to each user. No patient data is used to train models.

    The Future of Pharmaceutical Practice

    Artificial intelligence is already transforming many sectors. Pharmacy is no exception. But rather than having this transformation imposed on them, Quebec pharmacists have the opportunity to embrace it with a tool designed for them, by a team that understands their daily reality.

    Pharmia Atlas bridges the gap between the pharmacist’s clinical expertise and the power of AI — instant access to the full breadth of pharmaceutical knowledge, in a format that meets the demands of practice.

    Try Pharmia Atlas and discover how AI can become your best clinical research tool.

    app.pharmia.ca/atlas

  • Hello world!

    Welcome to WordPress. This is your first post. Edit or delete it, then start writing!